retatrutide and addiction Episode #228: Can Help Addiction? The Science Behind Dopamine Cravings - Dr. Trish Leigh Podcast I guess most people haven't
Description
WHERE ARE THEY THESE DAYS
The documented retatrutide experience mentioned that morning fatigue resolved with electrolyte supplementation
If symptoms persist, your provider may opt to keep you at the highest comfortable level rather than discontinue use
Projected retatrutide timeline (based on these patterns) Phase 3 trials began: 2024 (TRIUMPH program) Expected FDA submission: 2026-2027 Expected FDA approval: 2027-2028 Expected commercial availability: 2028 Expected stable widespread availability: 2029-2030 (assuming manufacturing ramp-up and shortage resolution) Key lesson from prior launches Demand for GLP-1 medications has consistently exceeded manufacturer projections
